Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001493152-26-010334

CEO & President acquired 25,000 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Equels Thomas K CEO & President 2026-03-12 Conversion +25,000 63,922 D
Derivatives
Equels Thomas K CEO & President 2026-03-12 Conversion · Series G Convertible Preferred Stock −25 0 D
Loading xslF345X05/ownership.xml…